Related Experiment Video
Updated: Jul 5, 2026
04:25
Local Hyperthermia for Warts Treatment
Published on: November 8, 2024
Cryosurgery during topical imiquimod: a successful combination modality for lentigo maligna
I D Bassukas1, C Gamvroulia, A Zioga
1Department of Skin and Venereal Diseases, and the Department of Pathology, University of Ioannina Medical School, Ioannina, Greece. ibassuka@cc.uoi.gr
International Journal of Dermatology
|April 17, 2008
Summary
This study shows that combining cryosurgery with topical imiquimod effectively treats lentigo maligna. This cryo-immunological approach offers a promising, sustained clearance for this skin cancer.
Area of Science:
- Dermatology
- Immunology
- Oncology
Background:
- Lentigo maligna is a challenging skin cancer, often treated with cryosurgery or topical imiquimod when surgery is not feasible.
- Limited treatment options exist for lentigo maligna, necessitating novel therapeutic strategies.
Observation:
- A patient with lentigo maligna was treated with a combination of topical imiquimod and cryosurgery.
- The treatment involved cryosurgery sessions concurrent with ongoing topical imiquimod application.
Findings:
- Sustained clearance of lentigo maligna was observed for 26 months post-treatment.
- The combined approach enhances tumor cell apoptosis and antiangiogenesis.
- It stimulates a potent anti-tumor immune response by attracting and maturing dendritic cells, leading to specific cell-mediated immunity.
Implications:
- Combined cryo-immunological therapy represents a promising treatment modality for lentigo maligna.
- This approach may offer a less invasive alternative for patients unsuitable for surgical excision.
- Further research into cryo-immunological treatments could advance skin cancer therapy.
Related Concept Videos
01:30Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:19Clinical Applications of Epidermal Stem Cells
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...